Display search results for ** instead (807 products)
03 Jun 2004  |  Global
The white paper, The UCB-Celltech Merger A Strategic Snapshot, includes the details of the merger, stock analysis, and product pipeline analysis of Celltech. The white paper includes analysis of Celltech's lead product CDP-870 and its market potential, rheumatoid arthritis and Crohns disease market overview, competitive analysis of biologics for...
USD 1,350.00 save 25 %
08 Apr 2014  |  North America
Overview of the HIMSS14 Annual Conference and Exhibition - The Frost & Sullivan Perspective on Top Trends in Health IT for 2014
The HIMSS Annual Conference and Exhibition is one of the premier gatherings for leading participants in the health IT industry. This venue brings together a vast array of global market participants vendors, customers, government officials, academics, and thought leaders looking to network and make new contacts, gain a comprehensive overview of ...
USD 1,312.50 save 25 %
22 Nov 2019  |  North America
Better Understand the Timeline of the Tariff War and What Triggered the Hostilities
As the US-China Tariff War continues to escalate, the Transformational Healthcare Team at global research firm Frost & Sullivan has made available an insight analysis exploring the threats and opportunities for US businesses in China. The insight analysis also examines the timeline and causes of the tariff war and explores why medical technology (M...
15 Nov 2019  |  Global
Key Factors Contributing to Digital Health Innovation
This report aims to highlight the potential of Israel in becoming one of the leading centres for digital health innovation, globally. The report also presents some of the innovative startups working in the digital health space, as an example of the country’s potential.--BEGIN PROMO--
- Market t...
04 Nov 2019  |  North America
An End-user Perspective on Laboratory Spending Reveals Modest 2020 Budget Increases Following Healthier 2019 Spending
Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2019 that centered around the state of their laboratories in 2019 and their expectations for 2020. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year...
31 Jan 2020  |  North America
COVID-19 Pandemic will Drive New Digital-tech Adoption in Drug Discovery and Testing Services, and Federal Funding will Encourage Stronger Product Pipelines
The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...
USD 1,275.00 save 15 %
21 Feb 2020  |  Europe
Growth in EU4 Tele-consultation Market will be Driven by Collaborative Business Models
Tele-consultation market is opening up in the EU-4 region with healthcare policies favoring telemedicine, as well as evolving reimbursement scenario. This has led to several companies providing solutions including tele-consultations, tele-diagnosis, tele-expertise, tele-monitoring, tele-surveillance and tele-assistance. These companies are offering...
USD 1,275.00 save 15 %
15 Jun 2009  |  North America
Preparing for an Aging Society: Challenges Faced by Healthcare System in European Union, Japan, and United States
Globally, nations are experiencing a decline in population growth rate accompanied by fall in mortality rate, increase in life expectancy and improvement in health condition. However, these trends have resulted in an increase in percent of aged people in the total population or an Aging Society. The segment gives an overview of the common demogra...
10 Jun 2009  |  North America
Expiring patents on revenue generating drugs, competition from generic drugs and increasing research and development cost, is forcing pharmaceutical manufacturers to often outsource drug discovery processes. Over the years pharmaceutical outsourcing has moved up the value chain from non core functions to even core functions. The segment gives an ov...
29 Jan 2010  |  North America
Amid Stimulus Measures to Bolster the Emerging Economies - What Challenges and Opportunities Lie for the Healthcare Industry?
Though most countries were affected by the current economic slowdown, the impact varied from country to country. The article looks into the affect of slowdown in six emerging countries, namely Brazil, Russia, China, India, Mexico and Poland and covers the highlights of economic stimulus measures adopted by these countries. The article also provides...